US Stock MarketDetailed Quotes

NAUT Nautilus Biotechnology

Watchlist
  • 2.440
  • +0.040+1.67%
Close Nov 25 16:00 ET
306.38MMarket Cap-4357P/E (TTM)

Nautilus Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nautilus Biotechnology Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.17
-0.13
+0.04
Beat Est.
-28.25%
--
+21.97%
Analyst Rating
Buy

Oct 31, 2024

Nautilus Biotechnology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Oct 29, 20242024/Q30.000 / 0.000--
Jul 30, 20242024/Q20.000 / 0.000--
Apr 30, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Oct 29, 20242024/Q30.000 / 0.000--
Jul 30, 20242024/Q20.000 / 0.000--
Apr 30, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Nautilus Biotechnology Earnings Reports

  • Nautilus Biotechnology | 10-Q: Q3 2024 Earnings Report

    Oct 29 16:10 ET

  • Nautilus Biotechnology | 8-K: Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

    Oct 29 14:28 ET

  • Nautilus Biotechnology | 10-Q: Q2 2024 Earnings Report

    Jul 30 16:18 ET

  • Nautilus Biotechnology | 8-K: Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

    Jul 30 14:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data